Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?

Daniel J. Brotman, Scott Kaatz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?'. Together they form a unique fingerprint.

Medicine & Life Sciences